Download curriculum vitae - Cairo University Scholars

CURRICULUM VITAE
DR.HANAN RAMADAN NASSAR
1
CURRICULUM VITAE
Name:
Current Job
Hanan Ramadan Nassar
Assistant professor of Medical Oncology and Hematology malignancies
National Cancer Institute, Cairo University.
Work address:
National Cancer Institute, Cairo University.
Telephone Number: mobile 00201249984668
Email:
[email protected]
EDUCATIONAL BACKGROUND :
 M.D. (Doctorate): In Medical Oncology, National Cancer Institute, Cairo University in
November, 2003.
 M.Sc. (Master’s Degree): (Internal Medicine): Kasr EL-Aini, Cairo University.
 M.B.B.Ch. Faculty of Medicine, Kasr El-Aini, Cairo University in December, 1990
and was signed excellent.
Others:
 European Society Medical Oncology (ESMO) examination in Medical Oncology on
September 13, 2008.
2
 Work experience:
 Assistant professor Medical Oncology,NCI, Cairo University 2011
 Assistant Consultant Medical Oncology at King Fahad Specialist Hospital-Dammam,
KSA, Oncology Center, from12/5/2006.
 Assistant professor Medical Oncology,NCI, Cairo University
 Lecturer of Medical Oncology: In the National cancer Institute-Cairo University from 11-2004.
 Assistant Lecturer of Medical Oncology: In the National Cancer Institute, Cairo
University from July 1996 to December 2003, and Egypt.
 Resident: In the National Cancer Institute, Cairo University from September 1993 to May
1996, and Egypt.
 House Officer: Cairo University Hospitals, Faculty of Medicine from March 1991 to
February 1992, Egypt.
 General Practitioner: Preventive Medical Health Center, Cairo , Egypt from 1992-1993
.
Work experiences include:
1- Dealing with hematological and solid malignancies.
 Initiation and interpretation of appropriate diagnostic studies.
 Initiation of treatment and participation in tumor boards.
 Follow up of both inpatients and outpatients to monitor response and treatment side
effects.
 Referral of patients to appropriate services when needed.
 Providing consultation to other services for opinion and plan.
 Performing skilled procedures as bone marrow aspiration and biopsy, lumbar
puncture, thoracocentesis, paracentesis.
 Clinical rounding with junior staff and residents.
3
2- Educational Activities:






Participation in weekly journal club
Involvement in updating departmental clinical practice guidelines.
Nursing education both academic and bedside.
Lectures for postgraduates.
Participation in domestic and international conferences.
Participating in quality program team.
Publications
International:
1. Prognostic value of serum vascular endothelial growth factor in Egyptian female with
metastastic triple negative breast cancer,Journal of Clinical Biochemistry,
42,(2009),1420-1426.
2. Her2 positive locally advanced breast cancer one or two entities abstract no (5085).
ESMO Multidisciplinary Congress 20 - 24 September 2009.
3. What is the optimal duration of Folfox- Bevacizumab in Metastatic colorectal cancer?
Poster in Annals of Oncology, volume 19/Supplement 3, May 2008.
4. Comparison of three modalities in 726 patients with inoperable hepatocellular
carcinoma, phase III study, one institution experience. Poster in ESMO conference .11th
World Congress on Gastrointestinal Cancer, Jun 2009.
5. Neoadjuvant platinum containing regimen for local advanced triple negative breast
cancer, Mohamed rahal, hanan rammadan, ehab Hassan, Ali Arini, Hesham Mosleh,
Ahmed Abdelwarith,Ahmed, Alfaraj, Hafez Halawani, Essam Senan, Nadia Al
Naimy. Abstract(338) in35TH ESMO congress, Milan 8-12 October 2010.
6. Evaluation of hepatocyte growth factor(HGF) as a prognostic indicator in acut myeloid
leukemia, HananRamadan Nassar ,Heba Raslan,Bassma Algamal. Poster
presentation(1163p) in35TH ESMO congress, Milan 8-12 October 2010.
7. FLT3 internal tandem duplication and JAK2 V617F mutations in de novo acute
myelogenous leukemia: relation with induction chemotherapy and overall
4
survival,Magda M Assem, Magda M Noshy, Ghada M Elsayed, Hanan R Nassar,
Gamal Thabet, Ghada M Sherif andAida K Ahmad. Life Science Journal 2012;9(4).
8. Survival of Patients with Locally Advanced Triple Negative Breast Cancer After
Neoadjuvant Platinum Containing Chemotherapy. Experience of a Single InstituteE.
Ibrahim, H. Ramadan, A. Arini, H. Mosleh and N. AlNaimy, Kasr El-aini J. Clin.
Oncol. nucl. med. vol. 7, no. 3-4, Jul.-Oct. 2011:33-37.
9. Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid
leukemia patients, Ghada M. Elsayed, Hanan R. Nassar , Amr Zaher , Essam H.
Elnoshokaty a, Manar M. Moneer, J Egyptian Nat Cancer Inst 2013.
10. Gastric carcinoma at Tanta Cancer Center: A comparative retrospective clinicopathological study of the elderly versus the non-elderly, Ahmed A. Zeeneldin, Hanan
Ramadan, Mosaad M. El Gammal,Magdy M. Saber, Dina Elgamal, Mohamed A.
Sherisher, Journal of the Egyptian National Cancer Institute ,Volume 26, Issue 3 ,
Pages 127-137, September 2014.
11. Evaluation of vascular endothelial growth factor as prognostic marker in hepatocellular
carcinoma treated by locoregional therapy. Oral presentation in MOFF conference
2013.
National

Expression of DCC (deleted in colorectal carcinoma) gene in adult AML correlation
with response to induction chemotherapy and overall survival. Egyptian Journal of
Hematology, volume(32),Number (3) Jun 2007.

FLT3 internal tandum duplication (FLT3/ITD) and D835 mutation in acute leukemia
of cytogenetic intermediate risk group by normal karyotyping, Egypt .J. Lab .med.
vol.(17),no(3) oct;2005.
5

Prognostic relevance of telomerase and BCL-2 in acute myeloid leukemia. Journal of
the Egyptian Society of Hematology &Research, vol.3, NO.1, March: 69-79, 2007.
 Folfox and bevacizumab as first line treatment in metastatic colorectal cancer
(Experience of a single Institute).Journal of Clinical Oncology and Nuclear
Medicine.vol.3, NO 3-4, July-oct.2007.
 The prognostic significance of ki67 nuclear proliferation antigen and p53 tumor
suppressor gene overexpression in aggressive B-cell lymphoma.vol.76, NO4,
Suppl.IV.December2008.
 Clinical prognostic factors of diffuse large B cell non Hodgkin lymphoma: A
retrospective study of 224 patients, Thoraya Abdelhamid, Mohamed Samra, Hanan
Ramadan Marowa Mehessin* , , Nadia Mokhtar, Accepted in National Cancer
Journal.2011
MEETING AND COURSES ATTENDED:
 The First Pan Arab Cancer Conference, the Third French Arab Oncology Meeting, 1996.
 The First International Symposium on Malignant Lymphoma, 1997.
 The 5th International Conference of Oncology (Breast Cancer), 2001.
 The 4th International Alexandria Oncology Conference and the European School of
Oncology (ESO) course, 2000.
 Annual Cancer Conference of the Egyptian Cancer society Danish cancer
society &Aarhus University hospital (9-11-2005).
 The 8 th Intenational coference of oncology (Gastrointestinal malignancies) 2004.
 Annual Cancer Conference of the Egyptian Cancer Society, Danish Cancer Society&
Aarhus University Hospital 9-11-02-2005.
 UICC-NCI- AMAAC JOINT CONFERENCE, MARCH 21-25-2005, CAIRO, EGYPT.
 European Society of Medical Oncology in collaboration with National Cancer Institute
Cairo University 26-29-NOVEMBER 2005.
6
 NCI-UICC-AMACC- joint conference cancer in the developing world march 2005.
 Scientific Conference on Lymphoma Awareness Day, in collaboration between King
Fahad Specialist Hospital –Dammam and Saudi Cancer Foundation on 13-14th
September 2006, Dammam, KSA.
 Scientific Symposium title Breast Cancer Leadership Program Modules I& II. 10 Hours
CME, DUBAI, UAE .MARCH 7,8-03-08.
 Outreach Oncology SYMPOSIUM JANUARY 22-2009-SAUDI ARAMCO OIL
EXHIBITION, DHAHRAN .8 HOURS CME
 Membership :
 Member of Egyptian Cancer Society.
 Member of Saudi Cancer Foundation.
 Member of ESMO.
REFERENCES

Prof DR H.M.KHALED
Minister of higher education
Professor of Medical oncology
NCI
Cairo University.

. Prof Dr Heba Elzawahry
Professor of Medical Oncology
Head of the Department of Medical Oncology
NCI
7
Cairo University.

Prof Dr Rabab Gaafar
Professor of Medical Oncology
NCI
Cairo University.
 Prof Dr .Mustafa. M. El-Serafi
Professor of Medical Oncology,
NCI
Cairo University
8